Hai cercato: Ciprofloxacin hydrochloride hydrate
26 risultati sono stati trovati
product information
/m-ch.vwr.com/de_CH/images/AP_Myco_1_A5222_Myco_2_A5233_and_Myco_3_A5240.pdf
product information 1 Treatment of Mycoplasma-infected Cells with Antibiotics Myco-1 (A5222) Myco-2 (A5233) and Myco-3 (A5240) Description The contamination of cells with mycoplasma is a very common problem even though it often goes unnoticed sinc...
cmm_catalog_title_150304.indd
/m-ch.vwr.com/it_CH/images/Compendium_201503_070_ProNet0811.pdf
cmm_catalog_title_150304.indd Complete Monograph Methods Solutions for regulated Pharmaceutical Instrumental Analysis Methods with HPLC FTIR KF AAS and ICP 2015 -1 Merck Millipore is a division of Content Molecular Structures 3 Applications Index ...
product information
/m-it.vwr.com/it_IT/images/AP_Myco_1_A5222_Myco_2_A5233_and_Myco_3_A5240.pdf
product information 1 Treatment of Mycoplasma-infected Cells with Antibiotics Myco-1 (A5222) Myco-2 (A5233) and Myco-3 (A5240) Description The contamination of cells with mycoplasma is a very common problem even though it often goes unnoticed sinc...
cmm_catalog_title_150304.indd
/m-it.vwr.com/it_IT/images/Compendium_201503_070_ProNet0811.pdf
cmm_catalog_title_150304.indd Complete Monograph Methods Solutions for regulated Pharmaceutical Instrumental Analysis Methods with HPLC FTIR KF AAS and ICP 2015 -1 Merck Millipore is a division of Content Molecular Structures 3 Applications Index ...
product information
/m-ch.vwr.com/fr_CH/images/AP_Myco_1_A5222_Myco_2_A5233_and_Myco_3_A5240.pdf
product information 1 Treatment of Mycoplasma-infected Cells with Antibiotics Myco-1 (A5222) Myco-2 (A5233) and Myco-3 (A5240) Description The contamination of cells with mycoplasma is a very common problem even though it often goes unnoticed sinc...
product information
/m-ch.vwr.com/it_CH/images/AP_Myco_1_A5222_Myco_2_A5233_and_Myco_3_A5240.pdf
product information 1 Treatment of Mycoplasma-infected Cells with Antibiotics Myco-1 (A5222) Myco-2 (A5233) and Myco-3 (A5240) Description The contamination of cells with mycoplasma is a very common problem even though it often goes unnoticed sinc...
cmm_catalog_title_150304.indd
/m-ch.vwr.com/fr_CH/images/Compendium_201503_070_ProNet0811.pdf
cmm_catalog_title_150304.indd Complete Monograph Methods Solutions for regulated Pharmaceutical Instrumental Analysis Methods with HPLC FTIR KF AAS and ICP 2015 -1 Merck Millipore is a division of Content Molecular Structures 3 Applications Index ...
cmm_catalog_title_150304.indd
/m-ch.vwr.com/de_CH/images/Compendium_201503_070_ProNet0811.pdf
cmm_catalog_title_150304.indd Complete Monograph Methods Solutions for regulated Pharmaceutical Instrumental Analysis Methods with HPLC FTIR KF AAS and ICP 2015 -1 Merck Millipore is a division of Content Molecular Structures 3 Applications Index ...
IP Mycoplasm
/m-ch.vwr.com/de_CH/images/IP_Mycoplasm.pdf
infoPoint Surveys of cultures from labs all over the world reveal a strong prevalence of contamination by Mycoplasma and other Mollicutes. Depending on the method of detection 10-40% of continuous cell lines have been tested positively. The specie...
IP Mycoplasm
/m-ch.vwr.com/fr_CH/images/IP_Mycoplasm.pdf
infoPoint Surveys of cultures from labs all over the world reveal a strong prevalence of contamination by Mycoplasma and other Mollicutes. Depending on the method of detection 10-40% of continuous cell lines have been tested positively. The specie...
IP Mycoplasm
/m-it.vwr.com/it_IT/images/IP_Mycoplasm.pdf
infoPoint Surveys of cultures from labs all over the world reveal a strong prevalence of contamination by Mycoplasma and other Mollicutes. Depending on the method of detection 10-40% of continuous cell lines have been tested positively. The specie...
IP Mycoplasm
/m-ch.vwr.com/it_CH/images/IP_Mycoplasm.pdf
infoPoint Surveys of cultures from labs all over the world reveal a strong prevalence of contamination by Mycoplasma and other Mollicutes. Depending on the method of detection 10-40% of continuous cell lines have been tested positively. The specie...
29188433AA Production of recombinant monoclonal an
/m-ch.vwr.com/it_CH/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-it.vwr.com/it_IT/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
ls ge29064277 20131210235846
/m-ch.vwr.com/fr_CH/images/ls_ge29064277_20131210235846.pdf
imagination at work Application note 29-0642-77 AB Chromatography systems Purification of an N-terminal histidine-tagged protein using ÄKTA™ start ÄKTA start eliminates the hassles of manual protein purification handling such as loading large samp...
ls ge29064277 20131210235846
/m-ch.vwr.com/de_CH/images/ls_ge29064277_20131210235846.pdf
imagination at work Application note 29-0642-77 AB Chromatography systems Purification of an N-terminal histidine-tagged protein using ÄKTA™ start ÄKTA start eliminates the hassles of manual protein purification handling such as loading large samp...
1 - 16 of 26